Table 2.
Pharmacological profile (n = 17) | |
---|---|
Antithrombotic therapy | |
Aspirin, n (%) | 4 (23.5) |
Warfarin, n (%) | 13 (76.5) |
Rate and/or rhythm control therapy | |
Antiarrhythmics, n (%) | 5 (29.4) |
β receptor antagonist, n (%) | 11 (64.7) |
RAAS inhibitors | |
ACE inhibitor, n (%) | 9 (52.9) |
Angiotensin receptor antagonist, n (%) | 5 (29.4) |
Other medications | |
Statin, n (%) | 6 (35.3) |